NanoFlares for the Detection of Circulating Cancer Stem Cells

$799,958U54FY2013CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications & trials

Paper 38346200 Paper 34893072 Paper 33692132 Paper 32437125 Paper 31131326 Paper 30613765 Paper 30193061 Paper 30187042 Paper 30089632 Paper 29714477 Paper 29388774 Paper 29156673 Paper 29115174 Paper 29078364 Paper 28933554 Paper 28876055 Paper 28808036 Paper 28804160 Paper 28717350 Paper 28373576 Paper 28196309 Paper 28061439 Paper 28008338 Paper 27960515 Paper 27931093 Paper 27920397 Paper 27762539 Paper 27740740 Paper 27601638 Paper 27538453 Paper 27537821 Paper 27523252 Paper 27439019 Paper 27398077 Paper 27244690 Paper 27148838 Paper 27133387 Paper 27069624 Paper 27062518 Paper 27053773 Paper 27050622 Paper 26964503 Paper 26936392 Paper 26928012 Paper 26699102 Paper 26601235 Paper 26587747 Paper 26511855 Paper 26495044 Paper 26465067 Paper 26452304 Paper 26398097 Paper 26335776 Paper 26335372 Paper 26313138 Paper 26305708 Paper 26297167 Paper 26271335 Paper 26195734 Paper 26166945 Paper 26119581 Paper 26097111 Paper 25980315 Paper 25902507 Paper 25895865 Paper 25895864 Paper 25838542 Paper 25830565 Paper 25824204 Paper 25818445 Paper 25775582 Paper 25738968 Paper 25723190 Paper 25695627 Paper 25689511 Paper 25671465 Paper 25652088 Paper 25600963 Paper 25487833 Paper 25462852 Paper 25437772 Paper 25417765 Paper 25404304 Paper 25393766 Paper 25393322 Paper 25366903 Paper 25310840 Paper 25284907 Paper 25226566 Paper 25144723 Paper 25037888 Paper 24983505 Paper 24961930 Paper 24946803 Paper 24937195 Paper 24930032 Paper 24902713 Paper 24841494 Paper 24817775 Paper 24756028

Abstract

Human cancers are represented by heterogeneous collections of malignant cells that must be eradicated for treatment to be successful. For many solid organ tumors, cancer stem cells (CSCs) are thought to be responsible for treatment failure and poor clinical outcomes. Accordingly, the detection of CSCs represents a significant priority with regard to prognostication, choice of treatment, and for assessing patient responses to inten/ention. Convenfional tools for the detecfion and isolation of CSCs are near exclusively protein limited. Intracellular mRNA targets have been used extensively for cancer cell sub-population phenotyping; however, detecfion of mRNA targets requires destruction of precious candidate cells for performing RT-PCR and sacrifices throughput. Either for basic science research or clinical use, the capability of simultaneous detecfion of both protein and mRNA markers in live cancer cell populafions, and in real fime, would be significantly enabling. This project aims to bring a new and enabling technology, 'NanoFlares', to bear on the detection and isolation of phenotypically distinct cancer stem cells (CSC). Taking advantage of the unique properties of gold nanoparticles surface functionalized with DNA (DNA Au-NPs), the NanoFlare technology provides the unique capability of phenotyping cell sub-populations simultaneously at the protein and mRNA level. Single-cell analysis is possible using confocal light microscopy while thousands of individual cell measurements can take place in high throughput using flow cytometry (FC) and fiuorescence activated cell sorting (FACS). Focusing initially on breast cancer, project success will have significant impact from the standpoint of basic science discovery in the context of CSCs and, ultimately, for pafients with all forms of localized and disseminated cancer where CSC detection and eradication could have a dramatic impact on patient outcomes.

View original record on NIH RePORTER →